| Pharmaceutical active ingredients: |
| Medroxyprogesterone Acetate |
| Available forms, composition and doses of Novo-Medrone: |
| Tablets; Oral; Medroxyprogesterone Acetate 10 mgTablets; Oral; Medroxyprogesterone Acetate 2.5 mgTablets; Oral; Medroxyprogesterone Acetate 5 mg |
| Novo-Medrone medical category: |
| Human:Depot contraceptivesOestrogens and progesterones and related synthetic drugsProgestins |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| G03AC06 - MedroxyprogesteroneG03DA02 - MedroxyprogesteroneL02AB02 - Medroxyprogesterone |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Novopharm |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
MPA | Medroxyprogesterone Acetate | Betapharm Arzneimittel |
| MPA | Medroxyprogesterone Acetate | Hexal |
| MPA Gyn 5 | Medroxyprogesterone Acetate | Hexal |
| MPA-Noury | Medroxyprogesterone Acetate | Organon |
| Non-Preg | Medroxyprogesterone Acetate | L.B.S.; Antah Pharma; Healol Pharmaceuticals |
| Penta-Medroxyprogesterone | Medroxyprogesterone Acetate | Pentapharm |
| Perlutex | Medroxyprogesterone Acetate | Leo Pharma; Bayer |
| Petogen | Medroxyprogesterone Acetate | Fresenius; Medidata |
| Planibu | Medroxyprogesterone Acetate | Fahrenheit |
| PMS-Medroxyprogesterone | Medroxyprogesterone Acetate | Pharmascience |